Clinical profiles, disease outcome and co- Morbidities among T.b. rhodesiense sleeping sickness patients in uganda

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Kato, Charles D ^a   Nanteza, Ann ^a   Mugasa, Claire ^a   Edyelu, Andrew ^b   Matovu, Enock ^a   Alibu, Vincent P ^a  

^a MAKERERE UNIVERSITY   (Uganda)

^b Lwala Hospital   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL DISCOMFORT; ADULT; AFRICAN TRYPANOSOMIASIS; AGE; ANOREXIA; ARTHRALGIA; ARTICLE; ASCITES; BACKACHE; BRAIN DISEASE; CHILL; CLINICAL FEATURE; COMORBIDITY; CONSCIOUSNESS DISORDER; COUGH HEADACHE; DIARRHEA; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE SEVERITY; DYSURIA; EDEMA; FATALITY; FEMALE; FEVER; HEPATOMEGALY; HUMAN; INCONTINENCE; JAUNDICE; LENGTH OF STAY; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALAISE; MALARIA; MALE; MENTAL DISEASE; MIDDLE AGED; MIXED INFECTION; MYALGIA; OUTCOME ASSESSMENT; PARALYSIS; PERIORBITAL EDEMA; PREVALENCE; PROGNOSIS; PRURITUS; RELAPSE; RESIDENTIAL AREA; RESTLESSNESS; RETROSPECTIVE STUDY; SEX DIFFERENCE; SOMNOLENCE; SPLENOMEGALY; STIFF NECK; SYPHILIS; THORAX PAIN; TREMOR; UGANDA; URINARY TRACT INFECTION; VISUAL IMPAIRMENT; VOMITING; WASTING SYNDROME; YOUNG ADULT; ADOLESCENT; TREATMENT OUTCOME; TRYPANOSOMA BRUCEI RHODESIENSE; TRYPANOSOMIASIS, AFRICAN; URINARY TRACT INFECTIONS;

TRYPANOSOMA BRUCEI RHODESIENSE;

ADOLESCENT; ADULT; COMORBIDITY; FEMALE; HUMANS; MALARIA; MALE; MIDDLE AGED; TREATMENT OUTCOME; TRYPANOSOMA BRUCEI RHODESIENSE; TRYPANOSOMIASIS, AFRICAN; UGANDA; URINARY TRACT INFECTIONS;

EID: 84923783101     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0118370     Document Type: Article

References (42)

1. Simarro PP, Cecchi G, Franco JR, Paone M, Diarra A, Ruiz-Postigo JA, et al. Estimating and mapping the population at risk of sleeping sickness. PLoS Negl Trop Dis. 2012; 6: e1859. doi: 10.1371/journal. pntd.0001859 PMID: 23145192
2. WHO. Control and surveillance of African trypanosomiasis: report of a WHO expert committee. WHO Tech Rep Ser. 2013; 984: 1-250. PMID: 24552089
3. Kuepfer I, Hhary EP, Allan M, Edielu A, Burri C, Blum JA. Clinical presentation of Tb rhodesiense sleeping sickness in second stage patients from Tanzania and Uganda. PLoS Negl Trop Dis. 2011; 5: e968. doi: 10.1371/journal.pntd.0000968 PMID: 21407802
4. MacLean LM, Odiit M, Chisi JE, Kennedy PG, Sternberg JM. Focus-Specific Clinical Profiles in Human African Trypanosomiasis Caused by Trypanosoma brucei rhodesiense. PLoS Negl Trop Dis. 2010; 4: e906. doi: 10.1371/journal.pntd.0000906 PMID: 21151878
5. Odiit M, Kansiime F, Enyaru J. Duration of symptoms and case fatality of sleeping sickness caused by Trypanosoma brucei rhodesiense in Tororo, Uganda. East Afr Med J. 1997; 74: 792-795. PMID: 9557424
6. Buyst H. The epidemiology of sleeping sickness in the historical Luangwa valley. Ann Soc Belg Med Trop. 1977; 57: 349-359. PMID: 345980
7. Atouguia J, Kennedy PG. Neurological aspects of human African trypanosomiasis. J Infect Dis. 2000; 1: 321-372.
8. Kennedy PG. Human African trypanosomiasis of the CNS: current issues and challenges. J Clin Invest 2004; 113: 496-504. PMID: 14966556
9. Pepin J, Milord F, Khonde A, Niyonsenga T, Loko L, Mpia B, et al. Risk factors for encephalopathy and mortality during melarsoprol treatment of Trypanosoma brucei gambiense sleeping sickness. Trans R Soc Trop Med Hyg. 1995; 89: 92-97. PMID: 7747321
10. Legros D, Evans S, Maiso F, Enyaru J, Mbulamberi D. Risk factors for treatment failure after melarsoprol for Trypanosoma brucei gambiense trypanosomiasis in Uganda. Trans R Soc Trop Med Hyg. 1999; 93: 439-442. PMID: 10674099
11. Matovu E, Seebeck T, Enyaru JC, Kaminsky R. Drug resistance in Trypanosoma brucei spp., the causative agents of sleeping sickness in man and nagana in cattle. Microb Infect. 2001; 3: 763-770.
12. Boraschi D, Alemayehu MA, Aseffa A, Chiodi F, Chisi J, Del Prete G, et al. Immunity against HIV/AIDS, malaria, and tuberculosis during co-infections with neglected infectious diseases: recommendations for the European Union research priorities. PLoS Negl Trop Dis. 2008; 2: e255. doi: 10.1371/journal.pntd. 0000255 PMID: 18575596
13. Chappuis F, Loutan L, Simarro P, Lejon V, Büscher P. Options for field diagnosis of human African trypanosomiasis. Clin Microbiol Rev. 2005; 18: 133-146. PMID: 15653823
14. Cheesebrough M (2002) Medical Laboratory Manual for Tropical Countries. Cambridge, UK: Tropical Health Technology Publications and Butterworth-Heinemann.
15. Fèvre E, Coleman P, Odiit M, Magona J, Welburn S, Woolhouse M. The origins of a new Trypanosoma brucei rhodesiense sleeping sickness outbreak in eastern Uganda. The Lancet. 2001; 358: 625-628. PMID: 11530149
16. Hutchinson O, Fevre E, Carrington M, Welburn S. Lessons learned from the emergence of a new Trypanosoma brucei rhodesiense sleeping sickness focus in Uganda. Lancet Infect Dis. 2003; 3: 42-45. PMID: 12505033
17. Selby R, Bardosh K, Picozzi K, Waiswa C, Welburn SC. Cattle movements and trypanosomes: restocking efforts and the spread of Trypanosoma brucei rhodesiense sleeping sickness in post-conflict Uganda. Parasit Vectors. 2013; 6: 281. doi: 10.1186/1756-3305-6-281 PMID: 24289452
18. Pépin J, Méda H. The epidemiology and control of human African trypanosomiasis. Adv Parasitol. 2001; 49: 71-132. PMID: 11461032
19. Pépin J, Mpia B, Iloasebe M. Trypanosoma brucei gambiense African trypanosomiasis: differences between men and women in severity of disease and response to treatment. Trans R Soc Trop Med Hyg 2002; 96: 421-426. PMID: 12497980
20. Fevre EM, Wissmann Bv, Welburn SC, Lutumba P. The burden of human african trypanosomiasis. PLoS Negl Trop Dis. 2008; 2: e333. doi: 10.1371/journal.pntd.0000333 PMID: 19104653
21. Kagira J, Maina N, Njenga J, Karanja S, Karori S, Ngotho J. Prevalence and types of coinfections in sleeping sickness patients in Kenya (2000/2009). J Trop Med. 2011; 2011.
22. Truc P, Lando A, Penchenier L, Vatunga G, Josenando T. Human African trypanosomiasis in Angola: clinical observations, treatment, and use of PCR for stage determination of early stage of the disease. Trans R Soc Trop Med Hyg. 2012; 106: 10-14. doi: 10.1016/j.trstmh.2011.10.002 PMID: 22093811
23. Blum J, Schmid C, Burri C. Clinical aspects of 2541 patients with second stage human African trypanosomiasis. Acta tropica. 2006; 97: 55-64. PMID: 16157286
24. Boa YF, Traore MA, Doua F, Kouassi-Traore MT, Kouassi BE, Giordano C. The different present-day clinical picture of human African trypanosomiasis caused by T. b. gambiense. Analysis of 300 cases from a focus in Daloa, Ivory Coast. Bull Soc Pathol Exot Filiales. 1988; 81: 427-444. PMID: 2848637
25. Eperon G, Schmid C, Loutan L, Chappuis F. Clinical presentation and treatment outcome of sleeping sickness in Sudanese pre-school children. Acta Trop. 2007; 101: 31-39. PMID: 17207760
26. Gelfand M. The early clinical features of Rhodesian trypanosomiasis with special reference to the "chancre"(local reaction). Trans R Soc Trop Med Hyg. 1966; 60: 376-379. PMID: 5919626
27. Blum J, Burri C, Hatz C, Kazumba L, Mangoni P, Zellweger MJ. Sleeping hearts: the role of the heart in sleeping sickness (human African trypanosomiasis). Trop Med Int Health. 2007; 12: 1422-1432. PMID: 18076548
28. Boatin B, Wyatt G, Wurapa F, Bulsara M. Use of symptoms and signs for diagnosis of Trypanosoma brucei rhodesiense trypanosomiasis by rural health personnel. Bull World Health Organ. 1986; 64:389. PMID: 3490318
29. Kennedy PG. Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness). Lancet Neurol. 2013; 12: 186-194. doi: 10.1016/S1474-4422(12)70296-X PMID: 23260189
30. MacLean, Odiit M, MacLeod A, Morrison L, Sweeney L, Cooper A, et al. Spatially and genetically distinct African Trypanosome virulence variants defined by host interferon-ã response. J Infect Dis. 2007; 196: 1620-1628. PMID: 18008245
31. Songa EB, Hamers R, Rickman R, Nantulya V, Mulla A, Magnus E. Evidence for widespread asymptomatic Trypanosoma rhodesiense human infection in the Luangwa Valley (Zambia). Trop Med Parasitol. 1991; 42: 389. PMID: 1796239
32. MacLeod A, Welburn S, Maudlin I, Turner CMR, Tait A. Evidence for multiple origins of human infectivity in Trypanosoma brucei revealed by minisatellite variant repeat mapping. Mol Biol Evol. 2001; 52: 290-301.
33. Docampo R, Moreno SN. Current chemotherapy of human African trypanosomiasis. Parasitol Res. 2003; 90: S10-S13. PMID: 12811544
34. Collins JM, Klecker RW Jr, Yarchoan R, Lane HC, Fauci AS, Redfield RR, et al. Clinical pharmacokinetics of suramin in patients with HTLV-III/LAV infection. J Clin Pharmacol. 1986; 26: 22-26. PMID: 3005375
35. Kaminsky R, Mäser P. Drug resistance in African trypanosomes. Curr Opin Anti-infect Invest Drugs. 2000; 2: 76-82.
36. Meda HA, Doua F, Laveissière C, Miezan TW, Gaens E, Brattegaard K, et al. Human immunodeficiency virus infection and human African trypanosomiasis: a case-control study in Côte d'Ivoire. Trans R Soc Trop Med Hyg. 1995; 89: 639-643. PMID: 8594681
37. Pepin J, Ethier L, Kazadi C, Milord F, Ryder R. The impact of human immunodeficiency virus infection on the epidemiology and treatment of Trypanosoma brucei gambiense sleeping sickness in Nioki, Zaire. Am J Trop Med Hyg. 1992; 47: 133-140. PMID: 1503182
38. Elias D, Britton S, Kassu A, Akuffo H. Chronic helminth infections may negatively influence immunity against tuberculosis and other diseases of public health importance. Expert Rev Anti Infect Ther. 2007; 5: 475-484. PMID: 17547511
39. Van Riet E, Hartgers FC, Yazdanbakhsh M. Chronic helminth infections induce immunomodulation: consequences and mechanisms. Immunobiology. 2007; 212: 475-490. PMID: 17544832
40. Nok AJ. Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis. Parasitol Res. 2003; 90: 71-79. PMID: 12743807
41. Lutumba P, Makieya E, Shaw A, Meheus F, Boelaert M. Human African trypanosomiasis in a rural community, Democratic Republic of Congo. Emerg Infect Dis. 2007; 13: 248. PMID: 17479887
42. Odiit M, Shaw A, Welburn S, Fevre E, Coleman P, McDermott J. Assessing the patterns of healthseeking behaviour and awareness among sleeping-sickness patients in eastern Uganda. Ann Trop Med Parasitol. 2004; 98: 339-348. PMID: 15228715